To study the role of eIF4E in cell transformation, we developed a series of peptides based on the conserved eIF4E-binding motifs in 4E-BPs and eIF4G [9] linked to the penetratin peptide-carrier sequence, which mediates the rapid transport of peptides across cell membranes. Surprisingly, introduction of these eIF4E-binding peptides into MRC5 cells led to rapid, dose-dependent cell death, with characteristics of apoptosis. Single alanine substitutions at key positions in the peptides impair their binding to eIF4E and markedly reduce their ability to induce apoptosis. A triple alanine substitution, which abolishes binding to eIF4E, renders the peptide unable to induce apoptosis. Our data provide strong evidence that the peptides induce apoptosis through binding to eIF4E. They do not induce apoptosis through inhibition of protein synthesis, as chemical inhibitors of translation did not induce apoptosis or affect peptide-induced cell death. Thus these new data indicate that eIF4E has a direct role in controlling cell survival that is not linked to its known role in mRNA translation.
The importance of eIF4E in translational regulation and cell growth is underscored by observations that overexpression of eIF4E leads both to increases in protein synthesis and to cellular transformation in human and mouse cells [4, 5] . The mechanism by which eIF4E overexpression leads to cell transformation is poorly understood. It is, however, thought to be through the increased translation of growth-related mRNAs, which are normally translationally repressed [1] . To study directly the role of eIF4E in cell transformation, we developed a series of biotinylated peptides based on the conserved eIF4E-binding motif within 4E-BPs and eIF4G [9] linked to the penetratin peptide carrier sequence (Figure 1a ; peptides BP1 and BP1 YLM-AAA are not biotinylated) [10] [11] [12] . The ability of the biotinylated peptides to bind recombinant human eIF4E in vitro was assessed by streptavidin-agarose pull-down assays. The peptides based on the eIF4E-binding site of human eIF4G, wheat eIF4G or 4E-BP2 (Hu4G, W4G and BP2) were each able to bind eIF4E in vitro, whereas these peptides with triple alanine substitutions at conserved residues and a scrambled peptide could not (Figure 1b , left panel). Single alanine substitutions at conserved aminoacid residues within the Hu4G-based peptide led either to reduction (Hu4G Y-A) or abolition (Hu4G L-A) of their ability to bind eIF4E in this assay (Figure 1b, left panel) . This pattern of behaviour closely matches our understanding of the molecular basis of the interaction between eIF4E and its binding protein partners [13] . The Hu4G peptide also bound eIF4E in cell lysates, whereas the Hu4G YLL-AAA variant did not (Figure 1b, right panel) .
To investigate the effect of eIF4E-binding peptides in living cells, 10 µM of the peptide BP2 was incubated with serum-deprived or serum-fed MRC5 cells. Unexpectedly, the addition of BP2 to 72 hour serum-starved MRC5 cells led to rapid cell death (within 1 hour) (Figure 1c, lane 4) . In contrast, serum-fed cells were insensitive to the effect of BP2 at this concentration ( Figure 1c (e) Visualisation of effects of peptides on the MPT. Serum-starved MRC5 cells were loaded with 0.1 µM JC1 for 30 min before addition of 10 µM peptide. Changes in mitochondrial permeability were viewed by laser scanning confocal microscopy (krypton/argon laser) using identical settings. Green channel, excitation 488 nm/emission 522 nm. Red channel, excitation 568 nm/emission 585 nm. Channels were collected separately to avoid crossover. Images were taken 5 min after addition of peptide.
further the effect of eIF4E-binding peptides, serumstarved MRC5 cells were incubated with various concentrations of the BP2, BP1, Hu4G and W4G peptides (Figure 1d-f) . Each of these peptides elicited rapid, dosedependent cell death (within 30 minutes with 20 µM peptide, and 1 hour with 10 µM), whereas the addition of the triple alanine substitution peptides, which are unable to bind eIF4E, had no significant effect on cell viability (Figure 1d-f) . The single alanine substituted peptide Hu4G Y-A, which has reduced ability to bind eIF4E in vitro, also had a reduced capacity to induce cell death (Figure 1e ). Another single alanine substitution peptide, Hu4G L-A, which was unable to bind eIF4E in vitro, had a severely reduced ability to induce cell death at concentrations up to 10 µM (Figure 1e) . At a concentration of 20 µM, however, this peptide could induce cell death, probably indicating some residual low-affinity binding to eIF4E not detected in the pull-down assay (Figure 1e ). All peptides that can bind eIF4E in vitro can induce cell death, even though they have very different sequences outside their common eIF4E-binding motif (Figure 1a ). In addition, peptides with single or triple alanine substitutions at conserved residues important in binding to eIF4E either had no significant effect on cell survival or a reduced ability to induce cell death. Taken together with the in vitro binding studies, these data underpin a strong structure-activity relationship and thus provide strong evidence that eIF4E-binding peptides induce cell death through their interaction with eIF4E.
During cell death induced by eIF4E-binding peptides, cells shrink and undergo blebbing, two characteristics of apoptosis (Figure 2a ). To investigate whether nuclear condensation and DNA cleavage, other characteristics associated with apoptosis, also occurred, we used a number of methodologies. FACS analysis of propidium-iodide-stained MRC5 cells treated with the Hu4G peptide revealed a shift in the DNA profile from G0/G1 to sub-G0/G1, indicating cell death and possible chromosomal DNA fragmentation and/or condensation (Figure 2b ). DNA fragmentation was confirmed using TdT-mediated dUTP nick end labelling (TUNEL) (Figure 2c ). DAPI staining of cell nuclei revealed that cells incubated with Hu4G presented signs of nuclear condensation, having either condensed nuclei or nuclei with a punctate appearance (Figure 2d ).
An early event considered decisive in apoptosis is the opening of the mitochondrial permeability transition (MPT) pore [14] [15] [16] . To characterise further the cell death induced by eIF4E-binding peptides, the development of the MPT was investigated in living MRC5 cells loaded with the fluorescent dye JC1 [15] . No changes in fluorescence were observed on addition of the inactive peptide Hu4G YLL-AAA (Figure 2e ). In contrast, addition of Hu4G led to a rapid increase (within 5 minutes) in the intensity of the green fluorescence concomitantly with a loss of orange fluorescence, indicative of a drop in the mitochondrial transmembrane potential, Ψ m , within the mitochondria as a result of MPT pore opening (Figure 2e) .
A conserved family of caspases (aspartic-acid specific cysteine proteases) are frequently activated during apoptosis [17] . No such activation was detected in the cell death induced by eIF4E-binding peptides (data not shown). Moreover, pretreatment of the MRC5 cells with ZVAD.fmk, a wide-spectrum caspase inhibitor, did not affect peptide-induced cell death (data not shown). Therefore, the cell death we observed appears not to involve caspase activation. These data provide evidence that peptide-induced cell death in MRC5 cells proceeds through a caspase-independent mechanism that presents some features of apoptosis. The rapidity with which the cells die and the apparent lack of caspase activation are not features associated with classical apoptosis. Caspase activation is, however, not a prerequisite for apoptosis [18, 19] . It has been reported that apoptosis-inducing factor (AIF), a protein associated with mitochondria, can induce rapid caspase-independent apoptosis [20] . Rapid cell death has also been observed in a number of other cell types, but not investigated in detail.
Cell death induced by eIF4E-binding peptides might possibly be a consequence of a general inhibition of translation. To study this, serum-starved MRC5 cells were treated with either cycloheximide or pactamycin, which inhibit elongation and initiation, respectively. These drugs essentially abolished protein synthesis (Figure 3a) , but had no effect on cell survival during a 2 hour experiment Brief Communication 795 ( Figure 3a ), indicating that a block in general translation is not sufficient to cause cell death over this time period. The possibility that the peptide-induced cell death involved upregulation or downregulation of the translation of a specific mRNA or subset of mRNAs was investigated. MRC5 cells were treated with cycloheximide or pactamycin, to prevent ongoing protein synthesis, before addition of Hu4G. This did not, however, result in any protection against the effect of Hu4G (Figure 3b) . Continued translation is thus not required for the peptides to induce cell death, and neither is regulation of translation of specific mRNA(s) involved.
Our data thus indicate that eIF4E has a direct role in controlling cell survival that is not linked to its role in translation. The mechanism underlying cell death induced by eIF4E-binding peptide is not clear. Death might be associated with a yet undefined function of eIF4E. It has recently been reported that eIF4E co-localises in the nucleus with splicing factors, and eIF4E may therefore have a role in splicing or RNA export [21] . As penetratinlinked peptides can enter all compartments of the cell, cell death might be a result of their interference with a nuclear function of eIF4E. It is also possible that deleterious perturbations in eIF4E function may directly trigger the apoptotic machinery. This could be a 'checkpoint' mechanism by which the cells sense the integrity of the translation machinery. Indeed, the rapidity of cell death suggests that binding of the peptides to eIF4E may directly signal the induction of cell death.
